Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-thioproline is a nonproteinogenic amino acid and a proline derivative characterized by the presence of a thiazolidine ring with an L-stereochemistry. It is also known as (R)-thiazolidine-4-carboxylic acid. Naturally occurring but rare, it can be formed in biological systems through the reaction of cysteine and formaldehyde. As an amino acid derivative, it has been studied for its antioxidant properties and potential role as a geroprotector—protecting cells from oxidative stress by acting as an efficient sacrificial antioxidant. Research suggests possible utility as a dietary supplement to protect against degenerative diseases associated with oxidative stress, such as Alzheimer’s disease, Parkinson’s disease, atherosclerosis, and certain cancers[1][2][7][8]. There are no approved pharmaceutical indications or clinical trials beyond preclinical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on L-thioproline.